Company attributes
Industry
AngelList URL
Pitchbook URL
Legal Name
Spark Therapeutics, Inc.
Parent Organization
Legal classification
Date Incorporated
2013
Number of Employees (Ranges)
501 – 1,000
Email Address
info@sparktx.com
Phone Number
+12152209300
+18557727589
Full Address
3737 Market Street Philadelphia, PA 19104 United States0
CIK Number
Place of Incorporation
Investors
DUNS Number
0794982410
IRS Number
462,654,4050
Founded Date
2013
0Total Funding Amount (USD)
122,800,000
Latest Funding Round Date
May 2014
Acquisition Transaction
Latest Funding Type
CAGE Code
7CUR00
Patents Assigned (Count)
2
Wellfound ID
Country
Other attributes
Acquirer
Company Operating Status
Active
SIC Code
2,8360
Wikidata ID
Spark Therapeutics is a developer of gene therapy treatments focused on treating debilitating genetic diseases. The company is working on developing gene therapies for inherited retinal disease, neurodegenerative diseases, and diseases addressed by targeting the liver. The company has three gene products in clinical development: one for hemophilia, a hemophilia A inhibitor, and a product for hemophilia B in partnership with Pfizer.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
